The government of British Columbia is taking essential measures to ensure that individuals with diabetes in the province have uninterrupted access to the crucial medication Semaglutide, sold under the brand name Ozempic. This decision comes amidst growing concerns about potential shortages due to increased demand for the drug in various regions. Ozempic, which is an injectable prescription medication intended for the treatment of Type 2 diabetes mellitus, contains the active ingredient Semaglutide. As of now, B.C. has not faced any shortages of the drug. However, PharmaNet data from the province reveals an unusually high proportion of Ozempic dispenses being purchased by United States patients from B.C.-based pharmacies. U.S. consumers are increasingly…